XBiotech Inc.
XBIT | NASDAQ
$2.18
-$0.01 (-0.46%)
At close: Sep 21, 2026, 4:00 PM ET
$2.18
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Market Data
Market Cap $66.46M
Enterprise Value $-43.06M
Beta 0.85
Average Volume 36.66K
Shares Outstanding (Diluted) 30.49M
Shares Change YoY 0%
Institutional Ownership 6.54%
Exchange NASDAQ
ISIN CA98400H1029
Price Performance
Price Change 1M -4.4%
Price Change 3M -6.4%
Price Change 6M -7.6%
Price Change YTD -8.4%
Price Change 1Y -20.7%
Price Change 3Y -50.0%
Price Change 5Y -84.8%
1M CAGR (ann.) -4.0%
1Y CAGR (ann.) -21.0%
5Y CAGR (ann.) -32.5%
All-Time CAGR -17.6%
Valuation
PE Ratio -1.47
Forward PE N/A
PEG Ratio 0.03
Forward PEG 0.03
PS Ratio N/A
Forward PS N/A
PB Ratio 0.52
P/FCF Ratio -1.63
P/Adj. FCF Ratio -1.61
P/OCF Ratio -1.64
EV/Sales N/A
EV/EBIT 1.13
EV/EBITDA 1.00
EV/FCF 1.05
Earnings Yield -67.9%
FCF Yield -61.4%
Adj. FCF Yield -62.2%
Financial Health
Net Cash $109.53M
Total Debt $0
Cash & Short-Term Investments $109.53M
Total Assets $133.65M
Current Ratio 33.15
Quick Ratio 33.15
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt N/A
Interest Coverage 0.00
Altman Z-Score 6.15
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -1.3%
Returns
Return on Assets -33.8%
Return on Equity -31.6%
Return on Invested Capital -37.0%
Return on Capital Employed -37.0%
Return on Tangible Assets -33.8%
Historical Growth (CAGR)
Revenue CAGR 3Y N/A
Revenue CAGR 5Y -92.4%
Revenue CAGR 10Y -8.5%
EPS CAGR 3Y -13.9%
EPS CAGR 5Y -10.9%
EPS CAGR 10Y -38.4%
FCF CAGR 3Y -26.9%
FCF CAGR 5Y -24.9%
FCF CAGR 10Y 4.8%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Aug 12, 2026
EPS Estimate (next Q) $0.03
EPS Growth Est (next Q) -150.0%
Revenue Est (next Q) $7M
Revenue Growth Est (next Q) N/A
Cash Flow
Operating Cash Flow $-40.7M
Free Cash Flow $-40.84M
Adj. Free Cash Flow $-41.37M
FCF Per Share -$1.34
OCF Per Share -$1.33
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $-332K
Operating Income $-48.22M
EBITDA $-43.19M
Net Income $-45.13M
EPS (Diluted) -$1.48
Revenue / Employee N/A
Profit / Employee $-518.77K
Employees 87
Add to Watchlist
Select watchlists to add or remove XBIT